Aplenzin

Bausch Health Patient Assistance Program Patient Guide: How to Get Aplenzin at Low or No Cost

Aplenzin (bupropion hydrobromide) is an extended-release antidepressant tablet used to treat major depressive disorder in adults, helping to improve mood, energy levels, and daily functioning by balancing brain chemicals like norepinephrine and dopamine.[1][2] The Bausch Health Patient Assistance Program (PAP) offers Aplenzin at no cost for up to 12 months to eligible uninsured or underinsured U.S. residents whose household income is at or below 300% of the Federal Poverty Level (FPL), provided they meet strict criteria like lacking prescription coverage for the drug.[1][2]

About Aplenzin

Aplenzin is a once-daily, extended-release form of bupropion hydrobromide, prescribed for adults with major depressive disorder (MDD). Unlike immediate-release bupropion, Aplenzin provides steady symptom relief over 24 hours, reducing risks like seizures when taken as directed. Common uses include treating persistent sadness, loss of interest, fatigue, and concentration issues. It's not for bipolar depression or smoking cessation (use Zyban instead). Always follow your doctor's dosing—typically starting at 348 mg daily, up to 522 mg. Side effects may include dry mouth, insomnia, or nausea; report seizures or mood changes immediately. This program ensures access if cost is a barrier.[1][3]

Who Qualifies?

Eligibility is reviewed case-by-case with no application fee. Key requirements:[1][2]

• Legal U.S. resident (includes Puerto Rico).
• Valid prescription for Aplenzin from a licensed U.S. healthcare provider.
• Treated as an outpatient (not in hospital, nursing home, prison, etc.).
• No insurance coverage for Aplenzin: uninsured, denied by commercial insurance (after appeals), or no coverage via Medicare Part D, Medicaid, VA, TRICARE, etc.
• Household income ≤ 300% FPL (see table below).
• Prescriber not excluded from federal programs.

Medicaid patients use a separate form; Medicare Part D patients may appeal but often need to reapply yearly.[1][2]

Income Eligibility Breakdown

Income limits are based on annual household gross income at 300% of the 2026 Federal Poverty Level (FPL). Use guidelines from aspe.hhs.gov/poverty-guidelines. Examples (approximate; verify current FPL):[2]

Notes: Include all household income sources. Program reconfirms annually; changes may end eligibility. Discount cards don't count as coverage.[1][2]

Insurance Requirements

• Uninsured for Aplenzin: Ideal candidates.
• Commercial insurance: Must be denied coverage and exhaust appeals.
• Government insurance (Medicare Part D, Medicaid, etc.): Generally ineligible unless denied specific drug coverage. Medicare patients terminated Dec 31; reapply yearly.
• Attach insurance cards (front/back) and pharmacy statements. No coverage = faster approval.[1][2][3]

Step-by-Step Application Process

1. Check eligibility at BauschHealthPAP.com or call for questions.
2. Download form: Use standard application (or Medicaid-only if applicable).[1][4]
3. Patient completes: Page 2 (info, insurance), Page 3 (sign authorization).
4. Prescriber completes: Pages 4-6 (diagnosis, prescription, certification). No stamped signatures for controlled substances; e-signatures OK.
5. Gather documents: Insurance cards, proof of income if requested (applications held without required info).
6. Submit: Fax 844-705-0160 or Mail to Bausch Health PAP, P.O. Box 991624, Louisville, KY 40269.[1][3]

Applications processed case-by-case; incomplete ones held.[1]

Timeline and Delivery

• Processing: Varies; typically weeks, but no fixed time stated. Follow up if delayed.[1]
• Approval: Up to 12 months supply, shipped directly to your home or pharmacy.
• Annual reconfirmation: Report income/insurance changes.[2]

Alternatives if Denied

• Appeal denial, especially Medicare cases.[2]
• Reapply after fixing issues (e.g., income proof).
• Other programs: Check RxAssist.org, NeedyMeds.org, or generic bupropion PAPs.
• Patient Access Network (PAN) Foundation or state programs for depression meds.
• Biosimilars: None for Aplenzin.
• Doctor may switch to affordable generics like bupropion HCl (Wellbutrin SR/XL).[3]

Disclaimer

This guide summarizes Bausch Health PAP based on available info as of 2026; rules change—verify at BauschHealthPAP.com. Not medical/financial advice. Consult your doctor/pharmacist. Program can modify/deny at discretion. Income tables approximate; use official FPL.[1][2] (Word count: 942)